11 results
8-K
EX-10.2
EYPT
EyePoint Pharmaceuticals Inc
24 Jun 21
Termination of a Material Definitive Agreement
6:03am
for any corporate purpose until applied to the purchase of Stock and/or refunded to Participants. Participants’ Accounts need not be segregated.
(i
8-K
EX-10.3
pb422to 2n50vusy
28 Jun 19
Departure of Directors or Certain Officers
4:02pm
424B5
pzlzz4wckd
2 Jul 07
Prospectus supplement for primary offering
12:00am
424B5
gsak13o4sq6 mradxnz3
2 Jul 07
Prospectus supplement for primary offering
12:00am
- Prev
- 1
- Next